280 related articles for article (PubMed ID: 25927412)
1. Association between epidermal growth factor gene +61A/G polymorphism and the risk of hepatocellular carcinoma: a meta-analysis based on 16 studies.
Jiang G; Yu K; Shao L; Yu X; Hu C; Qian P; Xie H; Li J; Zheng J; Zheng S
BMC Cancer; 2015 Apr; 15():314. PubMed ID: 25927412
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 gene polymorphisms and susceptibility to hepatocellular carcinoma: A meta-analysis based on 10 case-control studies.
Xu W; Huang Y; Zhang T; Zhao L; Fan J; Li L
J Cancer Res Ther; 2018; 14(Supplement):S105-S113. PubMed ID: 29578159
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between EGF +61A>G polymorphism and melanoma susceptibility in Caucasians: a HuGE review and meta-analysis.
Wu D; Wu Y; Zhang X; Cong P; Lv X
Gene; 2013 Feb; 515(2):359-66. PubMed ID: 23201894
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysis.
Zhong JH; You XM; Gong WF; Ma L; Zhang Y; Mo QG; Wu LC; Xiao J; Li LQ
PLoS One; 2012; 7(3):e32159. PubMed ID: 22403631
[TBL] [Abstract][Full Text] [Related]
5. Association between the risk of hepatitis virus-related hepatocellular carcinoma and EGF polymorphism: A PRISMA-compliant updated meta-analysis.
Wang Q; Xu L; Wu Q; Zhang M; Zhang J
Medicine (Baltimore); 2022 Oct; 101(42):e31280. PubMed ID: 36281156
[TBL] [Abstract][Full Text] [Related]
6. Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients.
Li Y; Xie Q; Lu F; Zhao J; Mao P; Li Z; Liu S; Zhuang H
Liver Int; 2010 Jan; 30(1):112-8. PubMed ID: 19840254
[TBL] [Abstract][Full Text] [Related]
7. Association between the HSPA1B ±1267A/G polymorphism and cancer risk: a meta-analysis of 14 case-control studies.
Kuang D; Chen W; Song YZ; Yu YY; Zhang DY; Wu L; Tang J
Asian Pac J Cancer Prev; 2014; 15(16):6855-61. PubMed ID: 25169537
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor 61A>G polymorphism is associated with risk of hepatocellular carcinoma: a meta-analysis.
Yang Z; Wu Q; Shi Y; Nie Y; Wu K; Fan D
Genet Test Mol Biomarkers; 2012 Sep; 16(9):1086-91. PubMed ID: 22852842
[TBL] [Abstract][Full Text] [Related]
9. Association between the epidermal growth factor 61*A/G polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Sun S; Jin GJ; Zhao Y; Kang H
Asian Pac J Cancer Prev; 2015; 16(7):3009-14. PubMed ID: 25854398
[TBL] [Abstract][Full Text] [Related]
10. Association between the EGF rs4444903 polymorphism and liver cancer susceptibility: a meta-analysis and meta-regression.
Li YL; Tian Z; Zhao L; Zhang CL
Genet Mol Res; 2014 Oct; 13(4):8066-79. PubMed ID: 25299191
[TBL] [Abstract][Full Text] [Related]
11. EGF +61A/G polymorphism contributes to increased gastric cancer risk: evidence from a meta-analysis.
Peng Q; Li S; Qin X; Lao X; Chen Z; Zhang X; Chen J
Cancer Cell Int; 2014; 14():134. PubMed ID: 25729328
[TBL] [Abstract][Full Text] [Related]
12. An updated meta-analysis between the association of XRCC1 Arg399Gln polymorphism and hepatocellular carcinoma risk.
Zhang XL; Lu Y; Yang S; Peng QL; Wang J; Xie L; Deng Y; He Y; Li TJ; Qin X; Li S
Asian Pac J Cancer Prev; 2014; 15(7):3273-8. PubMed ID: 24815482
[TBL] [Abstract][Full Text] [Related]
13. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
Li JF; Zheng EQ; Xie M
Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
[TBL] [Abstract][Full Text] [Related]
14. Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Luo T; Chen J; Liu JJ; Li H; You XM; Wang HL; Zhu SL; Li LQ
Onco Targets Ther; 2016; 9():4483-9. PubMed ID: 27499641
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of the effect of epidermal growth factor 61A/G polymorphism on the risk of hepatocellular carcinoma.
Shen XF; Zeng XT; Jian ZY; Zhou M; Zhou P; Zhang M
Oncol Lett; 2015 Nov; 10(5):3199-3205. PubMed ID: 26722312
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of tumor necrosis factor-alpha and hepatocellular carcinoma risk: a HuGE systematic review and meta-analysis.
Wei Y; Liu F; Li B; Chen X; Ma Y; Yan L; Wen T; Xu M; Wang W; Yang J
Dig Dis Sci; 2011 Aug; 56(8):2227-36. PubMed ID: 21336601
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-12B+1188A/C polymorphism contributes to increased hepatocellular carcinoma susceptibility: evidence from a meta-analysis.
Peng Q; Li S; Lao X; Chen Z; Li R; Qin X
Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):735-43. PubMed ID: 25445750
[TBL] [Abstract][Full Text] [Related]
18. EGF +61A>G polymorphism and gastrointestinal cancer risk: a HuGE review and meta-analysis.
Piao Y; Liu Z; Ding Z; Xu L; Guo F; Sun Q; Xie X
Gene; 2013 Apr; 519(1):26-33. PubMed ID: 23403233
[TBL] [Abstract][Full Text] [Related]
19. Association Between P2RX7 Gene and Hepatocellular Carcinoma Susceptibility: A Case-Control Study in a Chinese Han Population.
Duan S; Yu J; Han Z; Cheng Z; Liang P
Med Sci Monit; 2016 Jun; 22():1916-23. PubMed ID: 27272229
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-10 gene polymorphisms and hepatocellular carcinoma susceptibility: a meta-analysis.
Wei YG; Liu F; Li B; Chen X; Ma Y; Yan LN; Wen TF; Xu MQ; Wang WT; Yang JY
World J Gastroenterol; 2011 Sep; 17(34):3941-7. PubMed ID: 22025883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]